Research paper · research paper ·
TIPS
> Upheaval in the global external environment, including the recent COVID-19 pandemic, infectious disease outbreaks such as the Marburg virus, and the most recent development aid funding cuts, has created a sense of urgency among African nations to relook at health systems resilience and self-sufficiency in the supply of healthcare products. This Working Paper focuses on how South Africa’s strategic engagement in the Group of 20 (G20) could enhance its ability to mobilise international partnerships, influence global pharmaceutical policy, and attract investment for pharmaceutical manufacturing to facilitate export-led sector growth. Tweet Published in Trade and Industry back to top Join our newsletter Stay informed about the latest TIPS news, research and events. SIGN UP Category Search Search Vacancies
Abstract excerpted from the publisher page during the weekly research-corpus refresh. The full paper lives at the source.
Indexed in SA Policy Space from the publisher feed. The full paper, its citation, and any re-use rights live with TIPS.
Data as of 2026-05-11 · latest PMG meeting 2026-05-08